1. Home
  2. NVTS vs AMPH Comparison

NVTS vs AMPH Comparison

Compare NVTS & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • AMPH
  • Stock Information
  • Founded
  • NVTS 2014
  • AMPH 1996
  • Country
  • NVTS United States
  • AMPH United States
  • Employees
  • NVTS N/A
  • AMPH N/A
  • Industry
  • NVTS Semiconductors
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVTS Technology
  • AMPH Health Care
  • Exchange
  • NVTS Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • NVTS 1.3B
  • AMPH 1.2B
  • IPO Year
  • NVTS N/A
  • AMPH 2014
  • Fundamental
  • Price
  • NVTS $14.65
  • AMPH $23.78
  • Analyst Decision
  • NVTS Buy
  • AMPH Buy
  • Analyst Count
  • NVTS 7
  • AMPH 6
  • Target Price
  • NVTS $4.93
  • AMPH $35.50
  • AVG Volume (30 Days)
  • NVTS 66.9M
  • AMPH 379.2K
  • Earning Date
  • NVTS 11-03-2025
  • AMPH 11-05-2025
  • Dividend Yield
  • NVTS N/A
  • AMPH N/A
  • EPS Growth
  • NVTS N/A
  • AMPH N/A
  • EPS
  • NVTS N/A
  • AMPH 2.68
  • Revenue
  • NVTS $68,167,000.00
  • AMPH $722,679,000.00
  • Revenue This Year
  • NVTS N/A
  • AMPH $1.37
  • Revenue Next Year
  • NVTS $8.28
  • AMPH $6.93
  • P/E Ratio
  • NVTS N/A
  • AMPH $8.87
  • Revenue Growth
  • NVTS N/A
  • AMPH 1.37
  • 52 Week Low
  • NVTS $1.52
  • AMPH $20.39
  • 52 Week High
  • NVTS $16.85
  • AMPH $53.96
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 81.08
  • AMPH 33.63
  • Support Level
  • NVTS $7.50
  • AMPH $22.94
  • Resistance Level
  • NVTS $16.85
  • AMPH $24.20
  • Average True Range (ATR)
  • NVTS 1.30
  • AMPH 0.87
  • MACD
  • NVTS 0.86
  • AMPH -0.26
  • Stochastic Oscillator
  • NVTS 80.09
  • AMPH 19.33

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: